Medicus Pharma initiated at buy by Brookline Capital
Brookline Capital Markets initiated coverage of Medicus Pharma (NASDAQ:MDCX) with a buy rating, citing the potential of its ...
Medicus Pharma Ltd. Announces Change of Auditor
Medicus Pharma Ltd. has announced a change in its auditing firm, with MNP LLP resigning and EisnerAmper LLP being appointed as the new auditor. The transition, effective December 19, 2024, was ...
Hosted on MSN1mon
MDCX: Medicus Pharma 3Q 2024 Financial Results Reported; Stock Now Trades Both in Canada and on Nasdaq After Completing an IPO in the U.S.
On November 22, 2024, Medicus Pharma (NASDAQ:MDCX) (TSXV:MDCX) reported financial results for the third quarter ending September 30, 2024. Still being in the clinical trial stage, the company did ...
Medicus Pharma Ltd: Innovative D-MNA Product Positions Company for Success with Favorable Buy Rating
Medicus Pharma Ltd (MDCX) has received a new Buy rating, initiated by Brookline Capital Markets analyst, Kumaraguru Raja.Don't Miss Our ...
Nasdaq16d
Medicus Pharma announcs its INAD received MUMS from U.S. FDA
Medicus Pharma (MDCX) announces that its Investigational New Animal Drug, INAD, has received Minor Use in Major Species Designation, MUMS, from the U.S. Food and Drug Administration, FDA ...
Yahoo Finance25d
Medicus Pharma and Swanielle partner to expand BCC drug trial to Asia-Pacific
Canadian life sciences company Medicus Pharma has partnered with Japanese healthcare consultancy Swanielle to expand its Phase II clinical trial for treating basal cell carcinoma (BCC) into the ...
CNN1mon
Medicus Pharma Ltd
Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company, which engages in investing in novel life sciences and bio-technology companies. It focuses on identifying, acquiring ...
ServiceNow initiated, Brinker upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...
The Times Leader9d
King’s College event raises $237,655 for financially at-risk students
Ciaruffoli serves on numerous for-profit and nonprofit boards, including Chair of the Audit Committee of Medicus Pharma Ltd., ...
Yahoo Finance1mon
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical ...
Morningstar4d
Medicus Pharma Ltd MDCX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Wall Street Journal1mon
Medicus Pharma Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...